Literature DB >> 16822906

The stromal component of the marrow microenvironment is not derived from the malignant clone in MDS.

Aravind Ramakrishnan, Norihiro Awaya, Eileen Bryant, Beverly Torok-Storb.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16822906      PMCID： PMC1895486          DOI： 10.1182/blood-2006-02-001479

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes.

Authors:  S Alvi; A Shaher; V Shetty; B Henderson; B Dangerfield; F Zorat; L Joshi; S Anthwal; L Lisak; L Little; S Gezer; S Mundle; P L Reddy; K Allampallam; X Huang; N Galili; R Z Borok; A Raza
Journal:  Leuk Res       Date:  2001-11       Impact factor: 3.156

2.  Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro.

Authors:  Valérie Soenen-Cornu; Cristina Tourino; Marie-Laure Bonnet; Martine Guillier; Stéphane Flamant; Rami Kotb; Alain Bernheim; Jean-Henri Bourhis; Claude Preudhomme; Pierre Fenaux; Ali G Turhan
Journal:  Oncogene       Date:  2005-04-07       Impact factor: 9.867

3.  Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization.

Authors:  Eugenia Flores-Figueroa; Rosa Maria Arana-Trejo; Guillermo Gutiérrez-Espíndola; Adrián Pérez-Cabrera; Hector Mayani
Journal:  Leuk Res       Date:  2005-02       Impact factor: 3.156

4.  Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation.

Authors:  Norihiro Awaya; Kathleen Rupert; Eileen Bryant; Beverly Torok-Storb
Journal:  Exp Hematol       Date:  2002-08       Impact factor: 3.084

5.  Host origin of marrow stromal cells following allogeneic bone marrow transplantation.

Authors:  P J Simmons; D Przepiorka; E D Thomas; B Torok-Storb
Journal:  Nature       Date:  1987 Jul 30-Aug 5       Impact factor: 49.962
  5 in total
  10 in total

Review 1.  Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation.

Authors:  Charalampos Pontikoglou; Frédéric Deschaseaux; Luc Sensebé; Helen A Papadaki
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

Review 2.  Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis.

Authors:  Marc H G P Raaijmakers
Journal:  Int J Hematol       Date:  2012-01-06       Impact factor: 2.490

3.  The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.

Authors:  Xiang Li; A Mario Marcondes; Theodore A Gooley; H Joachim Deeg
Journal:  Blood       Date:  2010-06-18       Impact factor: 22.113

4.  Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity.

Authors:  Mineo Iwata; Manoj Pillai; Aravind Ramakrishnan; Robert C Hackman; H Joachim Deeg; Ghislain Opdenakker; Beverly Torok-Storb
Journal:  Blood       Date:  2007-01-01       Impact factor: 22.113

5.  Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes.

Authors:  Aristoteles A N Giagounidis; Ulrich Germing; Sabine Haase; Carlo Aul
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

Review 6.  Mesenchymal stem cells in immune-mediated bone marrow failure syndromes.

Authors:  Maria-Christina Kastrinaki; Konstantia Pavlaki; Aristea K Batsali; Elisavet Kouvidi; Irene Mavroudi; Charalampos Pontikoglou; Helen A Papadaki
Journal:  Clin Dev Immunol       Date:  2013-12-10

Review 7.  Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?

Authors:  Lisa Pleyer; Peter Valent; Richard Greil
Journal:  Int J Mol Sci       Date:  2016-06-27       Impact factor: 5.923

8.  Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations.

Authors:  Christian Scharenberg; Valentina Giai; Andrea Pellagatti; Leonie Saft; Marios Dimitriou; Monika Jansson; Martin Jädersten; Alf Grandien; Iyadh Douagi; Donna S Neuberg; Katarina LeBlanc; Jacqueline Boultwood; Mohsen Karimi; Sten Eirik W Jacobsen; Petter S Woll; Eva Hellström-Lindberg
Journal:  Haematologica       Date:  2016-11-24       Impact factor: 9.941

9.  Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia.

Authors:  Antonella Conforti; Simone Biagini; Francesca Del Bufalo; Pietro Sirleto; Adriano Angioni; Nadia Starc; Giuseppina Li Pira; Francesca Moretta; Alessandra Proia; Benedetta Contoli; Silvia Genovese; Claudia Ciardi; Maria Antonietta Avanzini; Vittorio Rosti; Francesco Lo-Coco; Franco Locatelli; Maria Ester Bernardo
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

10.  Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes.

Authors:  A J I S Rathnayake; H W W Goonasekera; V H W Dissanayake
Journal:  Anal Cell Pathol (Amst)       Date:  2016-08-29       Impact factor: 2.916
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.